The Food and Drug Administration (FDA) is being sued in two lawsuits after releasing its Final Rule on Laboratory Developed Tests (LDTs). The Final Rule requires laboratories to adhere to the same ...
Previously, this blog covered the FDA’s decision to regulate lab-developed tests (LDTs) as medical devices. However, a ruling from a federal district court in Texas earlier this year has changed that.
The US Food and Drug Administration (FDA) plans to scrutinize the safety and efficacy of lab-developed tests — those designed, manufactured, and used in a single laboratory — far more thoroughly in ...
Emerging markets equities can offer outsized potential and portfolio diversification benefits to investors for three reasons. First, emerging markets tend to exhibit a substantial demographic ...
The Global X DAX Germany ETF is the only US-listed ETF offering pure-play exposure to Germany’s prime equity benchmark- the DAX. DAX isn't as popular as EWG, which covers the MSCI Germany Index, but ...
IEFA offers higher recent returns and a significantly higher dividend yield than SPGM. SPGM provides broader global exposure including U.S. and emerging markets, while IEFA focuses on developed ...